Only physicians have the right to access trial data.

The trial results will be published in high-impact journals.

Participants are compensated financially regardless of study outcomes.

Participants are aware of potential risks and voluntarily agree to participate.

A preliminary analysis conducted before a trial starts.

The statistical software used for data analysis.

The main outcome used to assess the effectiveness of an intervention.

The number of participants enrolled in a study.

A secondary measure that supports the main research findings.

To eliminate the need for placebo groups.

To increase the number of participants in the trial.

To reduce study duration.

To balance participant characteristics across treatment groups.

To allow researchers to control the final results.

To adjust the research question to align with current trends.

To ensure the study follows ethical guidelines and protects participants.

To approve the study without modifications.

To evaluate whether the research will be financially profitable.

To determine the expected impact factor of the final publication.

They minimize bias by randomly assigning participants to groups.

They do not require ethical approval before starting.

They eliminate all sources of bias in research.

They use pre-existing data to analyze outcomes.

They require fewer participants than observational studies.